NCT04729959 · Interventional trial
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
Overall registry status Active not recruiting
Phase 2
Conditions Diffuse Astrocytoma, IDH-Wildtype, Recurrent Glioblastoma
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
- University of Pennsylvania/Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory